Skip to main content

AN2 Therapeutics, Inc.

ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001880438

In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by AN2 Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $11.6K in total
Open-market sells
5 filings
3 insiders, $343.0K in total
Insiders trading
4
Net value
−$331.4K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for AN2 Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for AN2 Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Trenor Cameron C. IIIChief Medical Officer116,667Sep 16, 20261
Readnour Robin ShaneDirector624,765IndirectSep 11, 20265
Williams Sarah JoannePrincipal Accounting Officer66,311Sep 4, 20264
FitzPatrick Margaret MDirector10,708Sep 2, 20263
Zakrzewski Joseph SDirector0IndirectAug 14, 20263
Aziz KabeerDirector59,106Jul 10, 20266
Marks Gilbert LynnDirector81,873Jul 10, 20266
Martin Patricia A.Director18,863Jul 10, 20266
Eizen Joshua MSee Remarks206,554Jul 10, 20265
Spigelman Melvin KDirector–Mar 23, 20262
Wong StephanieDirector–Mar 23, 20262
Chanda SanjayChief Development Officer118,823Mar 23, 20263
Easom EricChief Executive Officer368,630Mar 23, 20262
Day LucyChief Financial Officer118,363Mar 23, 20263
Prior Stephen DavidChief Strategy Officer59,086Jan 7, 20262
Leonard Braden Michael10% Owner3,017,432IndirectJun 16, 20250
RA Capital Healthcare Fund LP10% Owner300,853IndirectAug 13, 20240
Ra Capital Management, L.P.10% Owner300,853IndirectAug 13, 20240
Kolchinsky Peter10% Owner300,853IndirectAug 13, 20240
Shah Rajeev M.10% Owner300,853IndirectAug 13, 20240
RA Capital Nexus Fund II, L.P.10% Owner300,853IndirectAug 13, 20240
Eckburg PaulChief Medical Officer51,416Mar 29, 20240
Krause Kevin MichaelChief Strategy Officer31,914Mar 29, 20240
Adjuvant Global Health Technology Fund, L.P.10% Owner377,542IndirectJan 18, 20240
Adjuvant Global Health Technology Fund DE, L.P.10% Owner377,542IndirectJan 18, 20240
Adjuvant Capital Management, LLC10% Owner377,542IndirectJan 18, 20240
Adjuvant Capital GP, L.P.10% Owner377,542IndirectJan 18, 20240
Nazak Michael AdrianChief Accounting Officer–Feb 17, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 31, 2022 (view filing)Mar 292 daysAziz KabeerDirector, 10% OwnerPPurchase+166.7K$15.00+$2.50M+8.2%2.21M after
Mar 31, 2022 (view filing)Mar 292 daysReadnour Robin ShaneDirectorPPurchase+153.3K$15.00+$2.30M+45.9%487.6K after2 lots
Mar 31, 2022 (view filing)4:31 PM ETMar 292 daysRA Capital Healthcare Fund LP and 4 others10% OwnerPPurchase+1.67M$15.00+$25.0MNew position415.6K after2 lots
Mar 31, 2022 (view filing)8:15 PM ETMar 292 daysAdjuvant Global Health Technology Fund, L.P. and 1 other10% OwnerPPurchase+166.7K$15.00+$2.50M+8.2%2.21M afterDuplicate filing
Jun 15, 2022 (view filing)4:25 PM ETJun 13-142 daysRA Capital Healthcare Fund LP and 4 others10% OwnerPPurchase+81.4K$7.95+$647.4K+2.2%3.75M after2 lots
Jun 23, 2022 (view filing)4:31 PM ETJun 212 daysRA Capital Healthcare Fund LP and 4 others10% OwnerPPurchase+302$7.99+$2.41K0.0%3.75M after
Jun 24, 2022 (view filing)4:51 PM ETMar 2987 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerPPurchase+166.7K$15.00+$2.50M+8.2%2.21M afterAmendedDuplicate filing
Jul 28, 2022 (view filing)5:16 PM ETJul 26-272 daysRA Capital Healthcare Fund LP and 4 others10% OwnerPPurchase+23.2K$7.78+$180.7K+0.6%3.77M after2 lots
Aug 5, 2022 (view filing)4:06 PM ETAug 3-42 daysRA Capital Healthcare Fund LP and 4 others10% OwnerPPurchase+1.91K$7.51+$14.3K+0.1%3.77M after2 lots
Oct 24, 2022 (view filing)Oct 20-214 daysEasom EricChief Executive OfficerSSale−21.2K$16.47−$349.9K−81.2%4.91K after4 lots
Oct 26, 2022 (view filing)Oct 24-262 daysEasom EricChief Executive OfficerSSale−9.35K$15.76−$147.4K−65.6%4.91K after4 lots
Oct 28, 2022 (view filing)Oct 27-281 dayEasom EricChief Executive OfficerSSale−2.61K$15.19−$39.6K−34.7%4.91K after2 lots
Nov 2, 2022 (view filing)Oct 31-Nov 22 daysEasom EricChief Executive OfficerSSale−4.23K$15.27−$64.6K−46.3%4.91K after2 lots
Nov 7, 2022 (view filing)Nov 3-74 daysEasom EricChief Executive OfficerSSale−35.2K$15.86−$558.2K−87.8%4.91K after5 lots
Nov 9, 2022 (view filing)Nov 8-91 dayEasom EricChief Executive OfficerSSale−17.2K$15.60−$267.8K−77.8%4.91K after3 lots
Nov 14, 2022 (view filing)Nov 10-144 daysEasom EricChief Executive OfficerSSale−4.44K$15.32−$68.0K−47.5%4.91K after2 lots
May 15, 2023 (view filing)May 15Same dayEasom EricChief Executive OfficerPPurchase+10.0K$5.38+$53.8K+1.0%1.02M after
Aug 22, 2023 (view filing)5:01 PM ETAug 184 daysRA Capital Healthcare Fund LP and 4 others10% OwnerPPurchase+1.78M$9.00+$16.0M+52.9%5.14M after
Aug 25, 2023 (view filing)Aug 232 daysAziz KabeerDirector, 10% OwnerSSale−400$16.00−$6.40K−0.1%413.1K after2 lots
Aug 25, 2023 (view filing)4:31 PM ETAug 232 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−336$16.00−$5.38K0.0%2.18M after
Aug 25, 2023 (view filing)4:31 PM ETAug 232 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−64$16.00−$1.02K0.0%413.1K after
Sep 8, 2023 (view filing)Sep 6-72 daysAziz KabeerDirector, 10% OwnerSSale−7.14K$16.03−$114.5K−1.7%412.0K after4 lots
Sep 8, 2023 (view filing)4:59 PM ETSep 6-72 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−6.00K$16.03−$96.3K−0.3%2.18M after2 lots
Sep 8, 2023 (view filing)4:59 PM ETSep 6-72 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−1.14K$16.03−$18.2K−0.3%412.0K after2 lots
Sep 15, 2023 (view filing)Sep 132 daysAziz KabeerDirector, 10% OwnerSSale−400$16.00−$6.40K−0.1%411.9K after2 lots
Sep 15, 2023 (view filing)5:17 PM ETSep 132 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−336$16.00−$5.38K0.0%2.18M after
Sep 15, 2023 (view filing)5:17 PM ETSep 132 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−64$16.00−$1.02K0.0%411.9K after
Sep 29, 2023 (view filing)Sep 27-282 daysAziz KabeerDirector, 10% OwnerSSale−9.36K$16.11−$150.7K−2.2%410.4K after4 lots
Sep 29, 2023 (view filing)5:41 PM ETSep 27-282 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−7.87K$16.11−$126.7K−0.4%2.17M after2 lots
Sep 29, 2023 (view filing)5:41 PM ETSep 27-282 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−1.49K$16.11−$24.0K−0.4%410.4K after2 lots
Oct 3, 2023 (view filing)Sep 29-Oct 24 daysAziz KabeerDirector, 10% OwnerSSale−104.8K$16.27−$1.70M−21.0%393.7K after4 lots
Oct 3, 2023 (view filing)7:13 PM ETSep 29-Oct 24 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−88.1K$16.27−$1.43M−4.1%2.08M after2 lots
Oct 3, 2023 (view filing)7:13 PM ETSep 29-Oct 24 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−16.7K$16.27−$271.1K−4.1%393.7K after2 lots
Nov 16, 2023 (view filing)Nov 142 daysAziz KabeerDirector, 10% OwnerSSale−1.81K$16.15−$29.2K−0.5%393.4K after2 lots10b5-1
Nov 16, 2023 (view filing)6:59 PM ETNov 142 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−1.52K$16.15−$24.6K−0.1%2.08M after10b5-1
Nov 16, 2023 (view filing)6:59 PM ETNov 142 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−288$16.15−$4.65K−0.1%393.4K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysEasom EricChief Executive OfficerSSale−2.78K$20.09−$55.8K−56.6%2.13K after10b5-1
Jan 4, 2024 (view filing)6:06 PM ETJan 22 daysKrause Kevin MichaelChief Strategy OfficerSSale−2.58K$20.12−$52.0K−57.4%1.91K after10b5-1
Jan 11, 2024 (view filing)7:59 PM ETJan 92 daysKrause Kevin MichaelChief Strategy OfficerSSale−7.42K$20.14−$149.4K−79.5%1.91K after10b5-1
Jan 12, 2024 (view filing)Jan 102 daysReadnour Robin ShaneDirectorSSale−3.67K$21.93−$80.4K−0.7%485.8K after2 lots10b5-1
Jan 17, 2024 (view filing)Jan 125 daysReadnour Robin ShaneDirectorSSale−1.43K$21.91−$31.2K−0.3%485.1K after2 lots10b5-1
Jan 18, 2024 (view filing)Jan 162 daysAziz KabeerDirectorSSale−100.0K$19.65−$1.97M−20.9%377.5K after2 lots
Jan 18, 2024 (view filing)6:18 PM ETJan 162 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−84.1K$19.65−$1.65M−4.0%2.00M after
Jan 18, 2024 (view filing)6:18 PM ETJan 162 daysAdjuvant Global Health Technology Fund, L.P. and 3 others10% OwnerSSale−15.9K$19.65−$312.6K−4.0%377.5K after
Jan 19, 2024 (view filing)Jan 181 dayZakrzewski Joseph SDirectorSSale−100.0K$19.11−$1.91M−19.8%405.9K after
Aug 13, 2024 (view filing)5:03 PM ETAug 94 daysRA Capital Healthcare Fund LP and 4 others10% OwnerSSale−3.53M$1.08−$3.81M−92.1%300.9K after2 lots
Aug 14, 2024 (view filing)Aug 14Same dayLeonard Braden Michael10% OwnerPPurchase+1.50M$1.04+$1.56M+35.3%5.75M after
Nov 18, 2024 (view filing)Nov 18Same dayEasom EricChief Executive OfficerPPurchase+50.0K$1.00+$50.0K+4.9%1.07M after
Nov 20, 2024 (view filing)Nov 18-192 daysZakrzewski Joseph SDirectorPPurchase+25.0K$1.00+$25.1K+25.5%123.2K after2 lots
Nov 21, 2024 (view filing)Nov 19-202 daysReadnour Robin ShaneDirectorPPurchase+200.0K$1.07+$213.0K+63.5%514.8K after4 lots